NMT Logo
    • About NMT Medical
      • Who we are
      • Our History
      • Our Executive Team
      • Careers
        • Career Opportunities
        • Application for Employment
    • Structural Heart Repair
      • Ventricular Septal Defect
      • Atrial Septal Defect
      • Patent Foramen Ovale (PFO)
      • FDA Disclaimer
    • NMT Technology
      • Technology Overview
      • Clinical History
      • CardioSEAL
        • Clinical Trials
        • Technology Approach
      • STARFlex
        • Clinical Trials
        • Technology Approach
      • BioSTAR
        • Clinical Trials
        • Technology-Approach
    • Patient Education
      • Product FAQ
      • 10 Questions to ask your Doctor
    • Medical Professional
    • Investors
      • Corporate Profile
      • Stock Information
        • Historic Prices
      • Press Releases
      • Event Calendar
      • Archived Webcasts
      • Presentations
      • Corporate Governance
        • Officers & Directors
        • Governance Documents
        • Committee Composition
      • Annual Reports
      • Analyst Coverage
      • Fact Sheets
      • Clinical Trials
      • SEC Filings
      • Market Makers
      • Email Notification
      • Information Request
      • FAQs
    • Contact Us
      • Contact Information
      • Contact Us Form

Investor Relations

  • Investor Relations
    • Corporate Profile
    • Stock Information
    • Press Releases
    • Event Calendar
    • Archived Webcasts
    • Presentations
    • Corporate Governance
    • Annual Reports
    • Analyst Coverage
    • Fact Sheets
    • Clinical Trials
    • SEC Filings
    • Market Makers
    • Email Notification
    • Information Request
    • FAQs

Corporate Profile

email thisPDF viewPrint view
Market SummaryDesktop Summary

Trading Symbol

NMTI
ExchangeNASDAQ
Market Value ($M)9.76
Stock Quote $ 0.75
Change Up $ 0.04
5.63%
Volume76,457
As of November 21, 2008
Minimum 20 minute delay.


Press Releases
11/06/2008NMT Medical Announces Third-Quarter 2008 Financial Results

10/23/2008NMT Medical to Release Third-Quarter 2008 Financial Results on November 6

10/08/2008NMT Medical Completes Enrollment in Landmark PFO/Stroke Clinical Trial

10/02/2008NMT Medical Announces Revised Third Quarter and Year End 2008 Revenue Guidance

8/05/2008NMT Medical Announces Second-Quarter 2008 Financial Results


Contact Information
NMT Medical, Inc.
27 Wormwood St.
Boston, MA 02210
(617)737-0930

Investor Relations
Please contact us via email at:
info@nmtmedical.com


NMT Medical (NASDAQ: NMTI) is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT Medical is currently investigating the potential connection between a common heart defect that allows a right to left shunt or flow of blood through a defect like a patent foramen ovale (PFO) and brain attacks such as embolic stroke, transient ischemic attacks (TIAs) and migraine headaches. A common right to left shunt can allow venous blood, unfiltered and unmanaged by the lungs, to enter the arterial circulation of the brain, possibly triggering a cerebral event or brain attack. More than 28,000 PFOs have been treated globally with NMT's minimally invasive, catheter-based implant technology. NMT Medical was founded in 1986 and is headquartered in Boston, Massachusetts.

Stroke Opportunity
PFO has been implicated as a possible risk factor of embolic stroke and TIA, for which current treatments include lifelong drug therapy or open heart surgery. NMT estimates the worldwide market for stroke- and TIA-related PFO closure procedures at 250,000 annually.

Migraine Opportunity
Medical research suggests that PFO may be a factor in certain migraine headaches. Of the 30 million migraine sufferers in America, those who experience aura and have a PFO may represent up to a 1.5 million patient subset. This represents NMT’s U.S. target market.











Featured ReportUpcoming Events


2007 Annual Report

Webcast
NMT Medical Q3 2008 Earnings Conference Call
Thursday, November 6th, 2008
10:00 AM ET




Copyright 2008, © SNL Financial LC  Terms of Use

Quick Links

Conference Calendar
Press Releases
Webcasts
Careers 

family

"When you have children depend on you, migraine has a massive impact."

Liz Norwood

Learn More

 

Home | About NMT Medical | Structural Heart Repair | NMT Technology | Patient Education | Medical Professionals 
Investors | Contact Us | Privacy Policy | Glossary | Login 

All content © 2008 NMT Medical, Inc.
NMT Medical, Inc., 27 Wormwood Street, Boston, MA 02210 | 617.737.0930